GLP-1 Receptor Agonists in Addiction Treatment: The Next Big Thing or Just Hype?
Michael Weaver, MD, DFASAM. Professor and Medical Director, Center for Neurobehavioral Research on Addiction at the University of Texas Medical School, Houston, TX.
Noah Capurso, MD, MHS. Assistant Medical Director, Addiction Services Division, Connecticut Valley Hospital; Associate Clinical Professor of Psychiatry, Yale University; Editor-in-Chief, The Carlat Addiction Treatment Report.
Drs. Weaver and Capurso have no financial relationships with companies related to this material.